Royalty Pharma PLC (RPRX) (Q3 2026) Earnings Call Highlights: Raised Guidance, Strong Royalty ...
Royalty Pharma PLC (RPRX) lifted full-year 2026 Portfolio Receipts guidance for the third consecutive quarter as Royalty Receipts grew 9% and capital deployment reached $1.6 billion year to date. Related Stocks: RPRX ,